These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20727140)

  • 1. Compliance and treatment satisfaction of post menopausal women treated for osteoporosis. Compliance with osteoporosis treatment.
    Huas D; Debiais F; Blotman F; Cortet B; Mercier F; Rousseaux C; Berger V; Gaudin AF; Cotté FE
    BMC Womens Health; 2010 Aug; 10():26. PubMed ID: 20727140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of patients with postmenopausal osteoporosis in French primary healthcare.
    Blotman F; Cortet B; Hilliquin P; Avouac B; Allaert FA; Pouchain D; Gaudin AF; Cotté FE; El Hasnaoui A
    Drugs Aging; 2007; 24(7):603-14. PubMed ID: 17658910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to oral bisphosphonates: 30 more minutes in dosing instructions matter.
    Vytrisalova M; Touskova T; Ladova K; Fuksa L; Palicka V; Matoulkova P; Horak P; Stepan J
    Climacteric; 2015; 18(4):608-16. PubMed ID: 25495333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of osteoporosis and associated quality of life in post menopausal women.
    Cortet B; Blotman F; Debiais F; Huas D; Mercier F; Rousseaux C; Berger V; Gaudin AF; Cotté FE
    BMC Musculoskelet Disord; 2011 Jan; 12():7. PubMed ID: 21226917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene)].
    Rosa J; Vanuga P; Payer J; Svobodník A
    Vnitr Lek; 2008 Mar; 54(3):217-9, 221-4. PubMed ID: 18522288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women.
    Breuil V; Cortet B; Cotté FE; Arnould B; Dias-Barbosa C; Gaudin AF; Regnault A; Roborel de Climens A; Legrand E
    Osteoporos Int; 2012 Feb; 23(2):445-55. PubMed ID: 21625889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of patient-reported outcomes (PROs): treatment satisfaction, medication adherence, and quality of life (QoL) and the associated factors in postmenopausal osteoporosis (PMO) patients in Korea.
    Byun DW; Moon SH; Kim T; Lee HH; Park HM; Kang MI; Ha YC; Chung HY; Yoon BK; Kim TY; Chae SU; Shin CS; Yang KH; Lee JH; Chang JS; Kim SH; Kim IJ; Koh JM; Jung JH; Yi KW; Yoo JJ; Chung DJ; Lee YK; Yoon HK; Hong S; Kim DY; Baek KH; Kim HJ; Kim YJ; Kang S; Min YK
    J Bone Miner Metab; 2019 May; 37(3):563-572. PubMed ID: 30238428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis.
    Cotté FE; Fardellone P; Mercier F; Gaudin AF; Roux C
    Osteoporos Int; 2010 Jan; 21(1):145-55. PubMed ID: 19459025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates.
    Hadji P; Claus V; Ziller V; Intorcia M; Kostev K; Steinle T
    Osteoporos Int; 2012 Jan; 23(1):223-31. PubMed ID: 21308365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history, reasons for, and impact of low/non-adherence to medications for osteoporosis in a cohort of community-dwelling older women already established on medication: a 2-year follow-up study.
    Clark EM; Gould VC; Tobias JH; Horne R
    Osteoporos Int; 2016 Feb; 27(2):579-90. PubMed ID: 26286625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric properties of the Osteoporosis-specific Morisky Medication Adherence Scale in postmenopausal women with osteoporosis newly treated with bisphosphonates.
    Reynolds K; Viswanathan HN; O'Malley CD; Muntner P; Harrison TN; Cheetham TC; Hsu JW; Gold DT; Silverman S; Grauer A; Morisky DE
    Ann Pharmacother; 2012 May; 46(5):659-70. PubMed ID: 22510666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge and compliance from patients with postmenopausal osteoporosis treatment.
    Palacios S; Sánchez-Borrego R; Neyro JL; Quereda F; Vázquez F; Pérez M; Pérez M
    Menopause Int; 2009 Sep; 15(3):113-9. PubMed ID: 19723681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study.
    Hadji P; Papaioannou N; Gielen E; Feudjo Tepie M; Zhang E; Frieling I; Geusens P; Makras P; Resch H; Möller G; Kalouche-Khalil L; Fahrleitner-Pammer A
    Osteoporos Int; 2015 Oct; 26(10):2479-89. PubMed ID: 26018090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of gastrointestinal events on patient-reported outcomes in Asia-Pacific women with osteoporosis: baseline results of the MUSIC OS-AP study.
    Modi A; Ebeling PR; Lee MS; Min YK; Mithal A; Yang X; Baidya S; Sen S; Sajjan S
    Arch Osteoporos; 2017 Dec; 12(1):65. PubMed ID: 28718004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of a new fixed-combination pack of bisphosphonate, calcium and vitamin D in the therapy of osteoporosis: results of two quantitative patient research studies.
    Ringe JD; Fardellone P; Kruse HP; Amling M; van der Geest SA; Möller G
    Drugs Aging; 2009; 26(3):241-53. PubMed ID: 19358619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis.
    Imaz I; Zegarra P; González-Enríquez J; Rubio B; Alcazar R; Amate JM
    Osteoporos Int; 2010 Nov; 21(11):1943-51. PubMed ID: 19967338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal symptoms and association with medication use patterns, adherence, treatment satisfaction, quality of life, and resource use in osteoporosis: baseline results of the MUSIC-OS study.
    Modi A; Sen S; Adachi JD; Adami S; Cortet B; Cooper AL; Geusens P; Mellström D; Weaver J; van den Bergh JP; Nguyen AM; Sajjan S;
    Osteoporos Int; 2016 Mar; 27(3):1227-1238. PubMed ID: 26637321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient satisfaction in postmenopausal women treated with a weekly bisphosphonate transitioned to once-monthly ibandronate.
    Bonnick SL; Silverman S; Tanner SB; Martens M; Bachmann G; Kohles JD; Civitelli R
    J Womens Health (Larchmt); 2009 Jul; 18(7):935-43. PubMed ID: 19563245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of therapeutic compliance in women with osteoporosis].
    Carbonell Abella C; Guañabens Gay N; Regadera Anechina L; Marín Rives JA; Taverna Llauradó E; Ayechu Redín MP;
    Reumatol Clin; 2011; 7(5):299-304. PubMed ID: 21925445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of patient training on persistence, compliance, and tolerability of different dosing frequency regimens of bisphosphonate therapy: An observational study in Turkish patients with postmenopausal osteoporosis.
    Akarırmak Ü; Koçyiğit H; Eskiyurt N; Esmaeilzadeh S; Kuru Ö; Yalçinkaya EY; Peker Ö; Ekim AA; Özgirgin N; Çalış M; Rezvani A; Çevikol A; Eyigör S; Şendur ÖF; İrdesel J;
    Acta Orthop Traumatol Turc; 2016 Aug; 50(4):415-23. PubMed ID: 27524671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.